


About Us
Halolife Group was established in 2012, encompasses several subsidiaries.
Have efficient and experienced R&D and production team, supported by cGMP quality system.
Products cover chemical small-molecule drug API and formulations, peptides, small nucleic acid , and biologic drugs (including monoclonal antibodies, bispecific antibodies, and ADC drugs).
Markets covering China, the United States, Europe, the Middle East, Africa, and other countries or regions along the “Belt and Road” initiative.
Provide a full industry chain product supply, from key intermediates to active pharmaceutical ingredients (APIs) and formulations, as well as comprehensive support services covering factory construction, technology transfer, and product sales.

Europe
North Africa
Middle East
China
Southeast Asia
Partners
If you are listed as a partner on our website and believe that any of the displayed information violates your privacy rights, please contact us immediately. You may notify us via [specific contact information, such as email address or telephone number]. Upon verification of your claim, we will promptly remove or amend the relevant content to ensure full protection of your lawful rights and interests.






Business Scope
News
Pharmaceutical Engineering: Refining Medicines, a Promising Future!
2025-02-13

Pharmaceutical Engineering: A Boon to Life and Health
2025-02-13

The Formation and Development Trends of the Pharmaceutical Outsourcing Services Industry
2025-02-13


Contact Us
Our products and services are not limited to the above-mentioned scope. If the service or product you need is not listed, please feel free to contact us at any time.

Halolife (Xiamen) Technology Co., Ltd.

